Cytokines and anorexia: a brief overview.

  • 1 February 1998
    • journal article
    • review article
    • Vol. 25, 64-72
Abstract
Cytokine immunotherapy with interferon-alpha, interleukin-1, interleukin-2, or tumor necrosis factor-alpha is consistently associated with anorexia and other neurologic and neuropsychiatric manifestations. Preclinical and clinical studies have shown that cytokines induce anorexia when administered peripherally or into the brain. Cytokine-induced anorexia involves both peripheral and central nervous system mechanisms. Cytokines modulate gastrointestinal activities, cause metabolic changes, affect the endocrine system, and modulate the normal neurotransmitter/neuropeptide profile of the hypothalamus, all of which can influence eating behavior. The direct effects of interferon-alpha, interleukin-1beta, and tumor necrosis factor-alpha on glucose-sensitive neurons in two specific regions of the hypothalamus could cause profound changes in eating patterns in animals and humans. Cytokine immunotherapy also induces production of a large array of endogenous cytokines, which may act synergistically to cause anorexia, taste aversions, and other neuropsychiatric manifestations. A variety of approaches have been proposed for ameliorating cytokine-induced anorexia. These include dietary supplementation with specific fatty acids, megestrol acetate, and specific neuropeptides or peptide hormones that have the ability to modulate cytokine production or activity.

This publication has 0 references indexed in Scilit: